Holders

COEPTIS THERAPEUTICS HLDGS I

Q3 2025 13F holders

CUSIP
19207A116
Type
Equity
Class
*W EXP 10/28/202
Total Reported Value ($000, excl. options)
Manager Report date Value ($000) Shares Option type